Intesa Sanpaolo Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
122,202
+10,528
+9% +$275K 0.59% 39
2026
Q1
$3.14M Buy
111,674
+10,225
+10% +$272K 0.77% 32
2025
Q4
$2.53M Buy
+101,449
New +$2.56M 0.52% 49

Other funds holding PFE

Intesa Sanpaolo Wealth Management's PFE Position: Q2 2026 in Review

Intesa Sanpaolo Wealth Management increased its Pfizer (PFE) stake by 9.4% in Q2 2026, buying an estimated $275K and bringing the position to 122,202 shares worth $2.94M. The position accounts for 0.59% of the portfolio, ranked #39.

Intesa Sanpaolo Wealth Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.14M in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Intesa Sanpaolo Wealth Management held 122,202 shares of Pfizer worth $2.94M as of Q2 2026.
  • Intesa Sanpaolo Wealth Management bought 10,528 Pfizer shares in Q2 2026, an estimated $275K.
  • Pfizer made up 0.59% of Intesa Sanpaolo Wealth Management's portfolio in Q2 2026, its #39 holding.
  • Intesa Sanpaolo Wealth Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Intesa Sanpaolo Wealth Management's Pfizer position peaked at $3.14M in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Intesa Sanpaolo Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.